内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Thunen Shelley B. Insider active across 2 companies, notably RxSight, Inc.. Cumulatively, 13 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €411k. History available since 15 December 2023. The latest transaction was disclosed on 14 April 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Thunen Shelley B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
222,684 股Class A Common StockSEC:0001104659-26-076515:0
7,792 股@ US$4.33861.8% 占其流量Common StockSEC:0000950170-25-054439:0
15,000 股@ US$16.0013.3% 占其流量Common StockSEC:0000950170-24-111461:0
36,021 股0Class A Common StockSEC:0001104659-24-097060:0
16,505 股@ US$4.344.0% 占其流量Common StockSEC:0000950170-24-084038:0
10,000 股@ US$15.59838.9% 占其流量Common StockSEC:0000950170-24-080522:0
10,247 股@ US$15.59839.1% 占其流量Common StockSEC:0000950170-24-052283:0
8,857 股@ US$49.814525.2% 占其流量Common StockSEC:0000950170-24-040174:0
10,000 股@ US$15.59838.8% 占其流量Common StockSEC:0000950170-24-025874:0
6,900 股@ US$4.341.7% 占其流量Common StockSEC:0000950170-24-012317:0
4,500 股@ US$4.341.1% 占其流量Common StockSEC:0000950170-24-008423:0
10,000 股@ US$15.59838.7% 占其流量Common StockSEC:0000950170-24-000892:0
20,000 股@ US$15.6017.4% 占其流量Common StockSEC:0001209191-23-059041:0
About Thunen Shelley B
Thunen Shelley B is a declarant linked to AEON Biopharma, Inc. as Director, and to RxSight, Inc. with the role See remarks. They have 13 filings in total, and in the sampled recent filings from 2023-12-18 to 2026-06-22, total sell volume is EUR 410914 and the most common transaction nature is Exercise of options.